- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04574297
An Observational Study on the Natural Course of Chronic Pancreatitis
October 25, 2021 updated by: Zhuan Liao, Changhai Hospital
The Impact of Genetic and Environmental Factors on the Progression of Chronic Pancreatitis:An Observational Study
To explore the impact on genetic and environmental factors for clinical manifestation, and the progression of chronic pancreatitis, including development of pancreatic insufficiency and other complications.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
The present study was an observational study aimed to explore the impact of genetic factors (rare pathogenic variants of CP) and environmental factors(smoking and alcohol assumption) on the clinical manifestation and progression of CP.
The observation items included the pain patterns, incidence of complications of CP, pancreatic cancer and death.
Study Type
Observational
Enrollment (Actual)
798
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Consequent patients with a diagnosis of CP in Changhai Hospital between 2010 to 2014
Description
Inclusion Criteria:
- patients with a diagnosis of chronic pancreatitis
- agree to join the study and provide informed consent
Exclusion Criteria:
- autoimmune pancreatitis
- pancreatic cancer diagnosed within 2 years after the diagnosis of chronic pancreatitis
- the follow-up time less than 2 years
- patients presenting with diabetes and/or steatorrhea at onset of CP.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the Number of Patients Developing Pancreatic Insufficiency
Time Frame: 10 years
|
The primary endpoint was the number of patients developing pancreatic insufficiency, categorised as 1) diabetes and steatorrhea, 2) diabetes only, or 3) steatorrhea only.
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death
Time Frame: 20 years
|
all-cause death
|
20 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2011
Primary Completion (ACTUAL)
May 31, 2020
Study Completion (ANTICIPATED)
December 31, 2030
Study Registration Dates
First Submitted
September 27, 2020
First Submitted That Met QC Criteria
September 30, 2020
First Posted (ACTUAL)
October 5, 2020
Study Record Updates
Last Update Posted (ACTUAL)
November 30, 2021
Last Update Submitted That Met QC Criteria
October 25, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP-2011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pancreatitis
-
Changhai HospitalUnknownChronic Pancreatitis | Idiopathic Chronic PancreatitisChina
-
AbbottCompletedExocrine Pancreatic Insufficiency, Chronic PancreatitisJapan
-
Postgraduate Institute of Medical Education and...Completed
-
Dartmouth-Hitchcock Medical CenterCompleted
-
The Cleveland ClinicChiRhoClin, Inc.; The National Pancreas FoundationCompletedChronic PancreatitisUnited States
-
Massachusetts General HospitalTerminatedChronic PancreatitisUnited States
-
Winthrop University HospitalCelgene CorporationTerminatedChronic Pancreatitis
-
Beth Israel Deaconess Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Kangen Pharmaceuticals, IncCompletedChronic PancreatitisUnited States, Russian Federation, Ukraine
Clinical Trials on smoking and alcohol assumption
-
Brown UniversityTruth InitiativeCompletedAlcohol Drinking | Smoking CessationUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Karolinska Institutet; Aarhus University Hospital; Copenhagen... and other collaboratorsCompletedSmoking | Bladder Cancer | Alcohol ConsumptionDenmark
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH); National Center for Complementary and...CompletedTobacco Use | Alcohol Use, UnspecifiedUnited States
-
Bispebjerg HospitalRigshospitalet, DenmarkRecruitingSurgery | Risk Reduction | Life Style | Urological CancerDenmark
-
Centre Leon BerardTerminatedHead and Neck Squamous Cell Carcinoma (HNSCC) | Premalignant LesionFrance
-
Seoul National University HospitalActive, not recruiting
-
University of OklahomaNational Institute on Drug Abuse (NIDA); Oklahoma State UniversityRecruitingNicotine Dependence | Cigarette Smoking | Nicotine WithdrawalUnited States
-
Duke UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)TerminatedCigarette Smoking | Nicotine WithdrawalUnited States
-
ImbioNational Cancer Institute (NCI); Mayo Clinic; University of Michigan; University... and other collaboratorsCompleted